Showing posts with label DNA Polymerase Market. Show all posts
Showing posts with label DNA Polymerase Market. Show all posts

Tuesday, 24 April 2018

DNA Polymerase Market Latest Trends and Future Growth Study by 2025

Global DNA Polymerase Market: Overview
DNA polymerase is an enzyme which is necessary for assembling the nucleotides together on the DNA strand. DNA polymerase was discovered by Dr. Arthur Kornberg in 1955 in an E.coli cell. He had first discovered the DNA polymerase I. DNA polymerase is also an essential enzyme for DNA replication. With each cell division, DNA polymerase is required for the duplication of the cell’s DNA. It is through this that the genetic information is passed from one generation to the other. DNA polymerase functions by adding new nucleotide at the 3’ end of the new DNA strand. DNA polymerase also helps in correcting the mistakes in the new synthesized strand by the process known as ‘proofreading.’ In this process, incorrect coupling is recognized by DNA polymerase which then reverses its direction by one base pair. The incorrect part is further removed by the process called as excision. DNA polymerase is essential for the process of transcription and translation which results in protein synthesis.


Global DNA Polymerase Market: Drivers and Restraints

There is a huge potential for the growth of the DNA polymerase market with the increasing incidence of cancer, neurological disorders, genetic mutation, and due to the increasing number of chronic diseases. According to WHO, the number of deaths due to cancer is expected to increase more than 70% over a decade. Also, increasing number of recombinant medicines for treating chronic diseases will drive the growth of the DNA polymerase market. Increasing crime across globe will boost the use of DNA polymerase in forensic testing such as DNA fingerprinting, which will drive the growth of the market. However, few restraining factors such as high cost, ethical issues, and stringent regulatory approval are likely to slow the growth of the DNA polymerase market.

Global DNA Polymerase Market: Key Segments

The DNA polymerase market is segmented in terms of cell type, therapeutic application, according to the reagents used, end users, and geography. According to cell type, the DNA polymerase market is segmented into prokaryotes and eukaryotes. Prokaryotes are further segmented into DNA polymerase I, DNA polymerase II, DNA polymerase III, DNA polymerase IV, and DNA polymerase V. Based on Eukaryotes, the DNA polymerase market is further segmented into DNA polymerase α, δ and € and DNA polymerase γ. In terms of therapeutic application, DNA polymerase is used in treating cancer, neuro-generative diseases, genetic disorders, and also in forensic labs. Based on reagents used, the DNA polymerase market is segmented into antibodies, primers, buffers, and other reagents used. In terms of end users, the market is segmented into biotechnology companies, diagnostic centers, research institutes, and forensic laboratories.


According to geography, the DNA polymerase market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the DNA polymerase market in terms of geography due to extensive research carried out in this region and also due to well-structured healthcare facilities with advanced treatments. Europe is the second largest market for DNA polymerase due to wide-ranging research activities carried out in this region with all major companies owning high stakes in the region. Increasing mergers and acquisitions with medical technology being widely used has facilitated the growth of the DNA polymerase market. Asia Pacific is a lucrative market backed by countries such as India, China, and Japan. Increasing interest of top players in this region due to improving economic conditions and developing healthcare infrastructure are the major drivers of the DNA polymerase market. Also, extensive research carried out in this region and growing awareness regarding genetic testing is an important factor for the growth of the market. Latin America, and Middle East & Africa are emerging markets and are expected to expand at a significant growth rate.

Global DNA Polymerase Market: Key Players

The top players in the DNA polymerase market are Novus, Excell Bio, Biomiga, Stratagene, SYGNIS, F. Hoffmann-La Roche Ltd, Finnzymes, Cyagen, Tiangen, Genetimes and others.


About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Wednesday, 20 December 2017

DNA Polymerase Market to Reach a Value of US$ 389.4 Million by the End of 2027

Future Market Insights presents a detailed forecast and in-depth insights on the global DNA polymerase market in a new report titled ‘DNA Polymerase Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027).’ According to the report, the global DNA polymerase market is anticipated to record a compounded annual growth rate of 6.5% and reach a market value of US$ 389.4 Mn in 2027.


Staggering increase in the use of DNA polymerases in point-of-care and molecular diagnostics kits is expected to continue to influence the adoption of DNA polymerases. Increasing use of DNA polymerases in epigenetics research, in addition to the increasing investments in life sciences R&D is also expected to boost revenue growth of the global market. However, high cost of reagents and availability of alternative techniques are expected to limit market growth over the forecast period.
By product type, growth of the eukaryotic DNA polymerase segment will be positively impacted by the introduction of various innovative products such as high-fidelity DNA polymerase that show excellent results in whole blood and other samples containing crude lysates. These products have been used in direct PCR applications, with limited sample processing, which have been a constant requirement especially for high throughput applications. In addition, the use of PCR-based technologies in point-of-care tests, companion diagnostics and other applications have led to a major boost for the DNA polymerase market.


Manufacturers of DNA polymerases are entering into distribution agreements to extend product reach and collaborations to ensure they gain market share and remain competitive in global markets. Eukaryotic DNA polymerase segment is expected to hold the highest share of the market, as well as display strong growth, expanding at a CAGR of 6.7% over the forecast period. Among end use segments, molecular diagnostics companies are expected to hold the largest share of the global DNA polymerase market at over 31% market share in terms of revenue in 2027. However, the academic and research institutes segment is anticipated to expand at a robust growth rate of 7.4% over the forecast period.

FMI’s report segments the global DNA polymerase market on the basis of region into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa. This report assesses key trends driving each market segment and offers analysis and insights on the DNA polymerase market across specific regions. The market in North America is anticipated to dominate the global DNA polymerase market with maximum value share by end of 2027, accounting for over 56% in terms of revenue. In terms of value, the market in Latin America is expected to be the fastest growing, registering a CAGR of 7.8% over the forecast period. The market in Asia Pacific Excluding Japan is also expected to show a significant growth of 7.7% over the forecast period.


Some of the key competitors covered in this report include Thermo Fisher Scientific Inc, Roche Diagnostics, Agilent Technologies, Qiagen NV, Takara Bio Company, Merck KGaA, Genscript, Illumina, New England Biolabs, and Promega Corporation. These vendors in the global DNA polymerase market are expanding their business by launching new and innovative products tailored for both research and in-vitro applications. Companies are also focussing on emerging markets in Asia Pacific to increase their geographical presence and tap into various end use segments that have the ability to invest in R&D for life sciences as well as develop innovative diagnostics tools.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com

Website: www.futuremarketinsights.com